Silence Therapeutics plc (SLN) Tops Q2 EPS by 5c

Silence Therapeutics plc (NASDAQ: SLN) reported Q2 EPS of ($0.09), $0.05 better than the analyst estimate of ($0.14).

For earnings history and earnings-related data on Silence Therapeutics plc (SLN) click here.

You May Also Be Interested In

• TTEC Holdings (TTEC) Misses Q2 EPS by 22c ; Offers Guidance
• Energy Services of America Corporation (ESOA) Misses Q3 EPS by 2c
• Jefferies Downgrades Root, Inc. (ROOT) to Hold